The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.
|
|
NICE publishes new ovarian cancer quality standard
NICE has today (23 May) published a new quality standard for ovarian cancer, which states that an integrated approach to the diagnosis and management of the disease is fundamental to the delivery of high quality care to women.
May 23, 2012
|
|
NICE guideline to standardise opioid use in palliative care and address patients' concerns
A new clinical guideline published today (23 May) by the National Institute for Health and Clinical Excellence (NICE), will help ensure safe and consistent prescribing of opioids as a first-line treatment option to relieve pain for patients receiving palliative care for chronic or incurable illnesses.
May 23, 2012
|
|
NICE recommends new treatment option for people with common heart condition
NICE has published final guidance recommending rivaroxaban (Xarelto, Bayer HealthCare) as an option for the prevention of stroke and systemic embolism in people with atrial fibrillation.
May 23, 2012
|
|
NICE consults on updated recommendations for treating infertility
The National Institute for Health and Clinical Excellence (NICE) is currently updating its 2004 NHS guidance on the assessment and treatment of couples with fertility problems. Today (22 May), NICE has issued a draft version of the updated guideline for public consultation.
May 22, 2012
|
|
Revised patient access scheme and more information allow NICE to recommend abiraterone for prostate cancer
NICE, the healthcare guidance body, has issued new draft guidance recommending the use of abiraterone (Zytiga, Janssen) in combination with prednisone or prednisolone for the treatment of castration-resistant metastatic prostate cancer that has progressed after one docetaxel-containing therapy.
May 16, 2012
|
|
NICE seeks views on draft psoriasis guideline
People with psoriasis should be treated by their GPs whenever possible and only referred to dermatology specialists when there is a clinical need, suggests draft guidance from NICE. The recommendations are out today (Friday 11 May) for public consultation.
May 11, 2012
|
|
NICE Citizens Council report on assessing future costs and health benefits open for comment
The Citizens Council of the National Institute for Health and Clinical Excellence (NICE), which provides public input into the Institute?s work, has published a report on its meeting at which it discussed how NICE should assess future costs and health benefits. The public is now invited to comment on the Council members? views on the issue of discounting ? the way in which health benefits are valued and calculated over a very long period of time.
May 11, 2012
|
|
NICE unable to endorse new treatment for prostate cancer
NICE has today (11 May) published final guidance in which it recommends against the routine use of cabazitaxel (Jevtana, Sanofi) in combination with prednisone or prednisolone as a second line treatment for prostate cancer.
May 11, 2012
|
|
Draft guidance recommends Botox for preventing headaches in adults who have chronic migraine
Botox could soon become a NHS treatment option to prevent headaches in some adults who experience chronic migraine. NICE has published final draft guidance today (Friday 11 May) which recommends the injections for the condition.
May 11, 2012
|
|
NICE consults on new public health guidance aiming to help prevent obesity
The National Institute for Health and Clinical Excellence (NICE) is currently developing new public health guidance on community-wide action to help prevent obesity. Draft recommendations have been published on the NICE website for public consultation.
May 9, 2012
|
This page was last updated: 23 May 2012
